Author

Marc Lipsitch

Primary ORCID profile (0000-0003-1504-9213 · 4 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Marc LipsitchiD4 papers · Harvard University

Biology Disciplines

Click to filter author papers

Epidemiology· 2 Genomics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:simulation· 2 Research Focus:benchmarking· 1 Research Focus:gene regulatory network inference· 1 Approach:statistical model· 1 Assay:whole-genome sequencing· 1

Frequent Co-Authors

Colin J Worby· 2 shared Edward Goldstein· 1 shared Jacco Wallinga· 1 shared Matt T. Hitchings· 1 shared Rebecca F. Grais· 1 shared William P Hanage· 1 shared

Activity by Year

2016-2017 · peak 2/yr

Co-Author Collaboration Network

6 top collaborators · 5 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenomics

Colin J Worby

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Using simulation to aid trial design: ring-vaccination trials

Matt T. Hitchings, Rebecca F. Grais, Marc Lipsitch

This paper uses simulation to design ring-vaccination trials for Ebola-like diseases, finding that sample size and effectiveness estimates depend on vaccine properties and trial design parameters.

PLOS Neglected Tropical Diseases · Mar 22, 2017Peer-reviewedEpidemiology

Shared genomic variants: identification of transmission routes using pathogen deep sequence data

Colin J Worby, Marc Lipsitch, William P Hanage

This study uses deep sequence data to identify transmission routes of pathogens by analyzing shared genomic variants and demonstrates their effectiveness in outbreak investigations.

bioRxiv · Aug 1, 2016Genomics

Population effect of influenza vaccination under co-circulation of non-vaccine variants and the case for a multi-strain A/H3N2 vaccine component

Colin J Worby, Jacco Wallinga, Marc Lipsitch, Edward Goldstein

This study simulates the impact of influenza vaccination on co-circulating vaccine-type and variant strains, showing that a bivalent vaccine reduces overall infection incidence more effectively than a monovalent vaccine.

bioRxiv · May 20, 2016 · PreprintEpidemiology